GlassScriptPhysician profile
George A Korede
NPI 1205163144
$867.45
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $788 · 2023: $36.27 · 2024: $42.71.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $78.98.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $78.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $155.72 | 2019 | |
| Amgen INC. | $155.69 | 2019 | |
| Ucb, INC. | $121.37 | 2019-2024 | |
| Radius Health, INC. | $115.90 | 2019 | |
| Mallinckrodt Enterprises LLC | $59.11 | 2019 | |
| Hikma Pharmaceuticals USA | $34.14 | 2019 | |
| Celgene Corporation | $33.86 | 2019 | |
| Pfizer INC. | $32.36 | 2019 | |
| Horizon Therapeutics Plc | $26.40 | 2019 | |
| Lilly USA, LLC | $25.18 | 2019 | |
| Janssen Biotech, INC. | $21.46 | 2019 | |
| Abbvie INC. | $20.90 | 2019 | |
| Glaxosmithkline, LLC. | $20.39 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $11.71 | 2019 | |
| Medexus Pharma, INC. | $11.57 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $10.86 | 2019 | |
| Genentech USA, INC. | $10.83 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Korede listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.